MedTrace Logo

Protect Chronic Tibial Nerve Stimulator (CTNS) System

NCT02781636 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-09-09

No results posted yet for this study

Summary

30 patient Study. All patients implanted with StimGuard Protect System. Patient followed out to 90 days.

Conditions

  • Urge Incontinence

Interventions

DEVICE

Device: StimGuard Protect System

Lead implanted adjacent to tibial nerve. Wireless rechargeable system.

Sponsors & Collaborators

  • Uro Medical Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02781636 on ClinicalTrials.gov